Karachi, GlaxoSmithKline Pakistan (GLAXO), one of the country's leading pharmaceutical companies, reported no dividend declarations for the recent fiscal years, amid an earnings per share (EPS) of Rs. 7.73* for January-February 2024. With a daily weighted average rate of Rs. 83.94 and a high of Rs. 94.98, the company remains focused on overcoming operational hurdles and enhancing its market standing. Since its 1953 listing, GlaxoSmithKline Pakistan has been dedicated to improving the quality of human life, with a market lot size of 500 units.